European Endocrinology 15.2 – Autumn 2019
Welcome to the autumn edition of European Endocrinology!
In this issue we present authoritative, up-to-date information on a wide range of salient topics. While the global epidemic of type 2 diabetes (T2D) continues to be a major focus of clinical research, and the focus of some of the articles in this edition, we also include discussions on the relationship between obesity and secondary hypogonadism in men, and aim to highlight less common endocrine conditions.
Gezer et al. present a case of a patient with MEN1 syndrome with inoperable metastatic gastroenteropancreatic neuroendocrine tumours (GEP-NETs) who was treated with 177Lu-DOTATATE. Al-Sharefi et al. present a retrospective study examining the clinical presentation and outcomes of PHAEO/PG in NF1.
We would like to thank all expert authors who gave their time and effort to produce an insightful selection of articles and hope that you will find this edition an enjoyable and informative read.